Stock Market & Financial Investment News

News Breaks September 4, 2012 06:33 EDT MRX Medicis upgraded to Neutral from Underperform at Credit Suisse Medicis (MRX) is being bought by Valeant (VRX) for $44 per share cash. News For MRX From The Last 14 Days Check below for free stories on MRX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for MRX Sign up for a free trial to see the rest of the stories you've been missing.